Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kairos Pharma (KAPA) Accounts Payables (2024 - 2025)

Historic Accounts Payables for Kairos Pharma (KAPA) over the last 2 years, with Q2 2025 value amounting to $676000.0.

  • Kairos Pharma's Accounts Payables changed N/A to $676000.0 in Q2 2025 from the same period last year, while for Jun 2025 it was $676000.0, marking a year-over-year change of. This contributed to the annual value of $992000.0 for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q2 2025, Kairos Pharma's Accounts Payables is $676000.0.
  • In the past 5 years, Kairos Pharma's Accounts Payables ranged from a high of $1.5 million in Q3 2024 and a low of $676000.0 during Q2 2025